BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29496174)

  • 1. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.
    Singh MK; Pooja D; Ravuri HG; Gunukula A; Kulhari H; Sistla R
    Phytomedicine; 2018 Feb; 40():48-54. PubMed ID: 29496174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate.
    Qiao H; Chen L; Rui T; Wang J; Chen T; Fu T; Li J; Di L
    Int J Nanomedicine; 2017; 12():1033-1046. PubMed ID: 28223797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
    Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
    Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies.
    Patel HP; Chaudhari PS; Gandhi PA; Desai BV; Desai DT; Dedhiya PP; Vyas BA; Maulvi FA
    Int J Pharm; 2021 May; 600():120474. PubMed ID: 33737093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-effective method to prepare curcumin nanosuspensions with enhanced oral bioavailability.
    Wang Y; Wang C; Zhao J; Ding Y; Li L
    J Colloid Interface Sci; 2017 Jan; 485():91-98. PubMed ID: 27657837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing oral bioavailability of diacerein: Simultaneous portal blood absorption and lymphatic delivery.
    El-Laithy HM; Basalious EB; El-Hoseiny BM; Adel MM
    Int J Pharm; 2015 Jul; 490(1-2):146-54. PubMed ID: 26002566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
    Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of TPGS/PVA-based nanosuspension for enhancing dissolution and oral bioavailability of ticagrelor.
    Na YG; Pham TMA; Byeon JJ; Kim MK; Han MG; Baek JS; Lee HK; Cho CW
    Int J Pharm; 2020 May; 581():119287. PubMed ID: 32243963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition.
    Rahim H; Sadiq A; Khan S; Amin F; Ullah R; Shahat AA; Mahmood HM
    Int J Nanomedicine; 2019; 14():6287-6296. PubMed ID: 31496686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption.
    Ghosh I; Schenck D; Bose S; Ruegger C
    Eur J Pharm Sci; 2012 Nov; 47(4):718-28. PubMed ID: 22940548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement.
    Gera S; Talluri S; Rangaraj N; Sampathi S
    AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: Physicochemical and pharmacokinetic investigation.
    Geng T; Banerjee P; Lu Z; Zoghbi A; Li T; Wang B
    Eur J Pharm Sci; 2017 Nov; 109():200-208. PubMed ID: 28811130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
    Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
    Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication of Stable Apigenin Nanosuspension with PEG 400 as Antisolvent for Enhancing the Solubility and Bioavailability.
    Xu R; Jiang C; Zhou L; Li B; Hu Y; Guo Y; Xiao X; Lu S
    AAPS PharmSciTech; 2021 Dec; 23(1):12. PubMed ID: 34881399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N; Janga KY
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel l-sulpiride-loaded quaternary microcapsule: Effect of TPGS as an absorption enhancer on physicochemical characterization and oral bioavailability.
    Kim DS; Kim DW; Kim KS; Choi JS; Seo YG; Youn YS; Oh KT; Yong CS; Kim JO; Jin SG; Choi HG
    Colloids Surf B Biointerfaces; 2016 Nov; 147():250-257. PubMed ID: 27518457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation.
    Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
    Drug Deliv; 2015; 22(4):552-61. PubMed ID: 24512268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of surface treatment on the brain delivery of curcumin nanosuspension: in vitro and in vivo studies.
    Dibaei M; Rouini MR; Sheikholeslami B; Gholami M; Dinarvand R
    Int J Nanomedicine; 2019; 14():5477-5490. PubMed ID: 31409999
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigation of a nanosuspension stabilized by Soluplus® to improve bioavailability.
    Yang H; Teng F; Wang P; Tian B; Lin X; Hu X; Zhang L; Zhang K; Zhang Y; Tang X
    Int J Pharm; 2014 Dec; 477(1-2):88-95. PubMed ID: 25455766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryoprotectant choice and analyses of freeze-drying drug suspension of nanoparticles with functional stabilisers.
    Wang L; Ma Y; Gu Y; Liu Y; Zhao J; Yan B; Wang Y
    J Microencapsul; 2018 May; 35(3):241-248. PubMed ID: 29624090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.